Full metadata record

DC Field Value Language
dc.contributor.authorLee, Hyosung-
dc.contributor.authorPark, Ki Duk-
dc.contributor.authorTorregrosa, Robert-
dc.contributor.authorYang, Xiao-Fang-
dc.contributor.authorDustrude, Erik T.-
dc.contributor.authorWang, Yuying-
dc.contributor.authorWilson, Sarah M.-
dc.contributor.authorBarbosa, Cindy-
dc.contributor.authorXiao, Yucheng-
dc.contributor.authorCummins, Theodore R.-
dc.contributor.authorKhanna, Rajesh-
dc.contributor.authorKohn, Harold-
dc.date.accessioned2024-01-20T09:30:48Z-
dc.date.available2024-01-20T09:30:48Z-
dc.date.created2021-08-31-
dc.date.issued2014-07-24-
dc.identifier.issn0022-2623-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/126579-
dc.description.abstractWe prepared 13 derivatives of N-(biphenyl-4'-yl)methyl (R)-2-acetamido-3-methoxypropionamide that differed in type and placement of a R-substituent in the terminal aryl unit. We demonstrated that the R-substituent impacted the compound's whole animal and cellular pharmacological activities. In rodents, select compounds exhibited excellent anticonvulsant activities and protective indices (PI = TD50/ED50) that compared favorably with clinical antiseizure drugs. Compounds with a polar, aprotic R-substituent potently promoted Na+ channel slow inactivation and displayed frequency (use) inhibition of Na+ currents at low micromolar concentrations. The possible advantage of affecting these two pathways to decrease neurological hyperexcitability is discussed.-
dc.languageEnglish-
dc.publisherAMER CHEMICAL SOC-
dc.subjectION CHANNELS-
dc.subjectANTIEPILEPTIC DRUGS-
dc.subjectLACOSAMIDE-
dc.subjectEXPRESSION-
dc.subjectLIDOCAINE-
dc.subjectDISCOVERY-
dc.subjectEPILEPSY-
dc.subjectCURRENTS-
dc.subjectTARGETS-
dc.subjectMODELS-
dc.titleSubstituted N-(Biphenyl-4 '-yl)methyl (R)-2-Acetamido-3-methoxypropionamides: Potent Anticonvulsants That Affect Frequency (Use) Dependence and Slow Inactivation of Sodium Channels-
dc.typeArticle-
dc.identifier.doi10.1021/jm500707r-
dc.description.journalClass1-
dc.identifier.bibliographicCitationJOURNAL OF MEDICINAL CHEMISTRY, v.57, no.14, pp.6165 - 6182-
dc.citation.titleJOURNAL OF MEDICINAL CHEMISTRY-
dc.citation.volume57-
dc.citation.number14-
dc.citation.startPage6165-
dc.citation.endPage6182-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000339540800026-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusION CHANNELS-
dc.subject.keywordPlusANTIEPILEPTIC DRUGS-
dc.subject.keywordPlusLACOSAMIDE-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordPlusLIDOCAINE-
dc.subject.keywordPlusDISCOVERY-
dc.subject.keywordPlusEPILEPSY-
dc.subject.keywordPlusCURRENTS-
dc.subject.keywordPlusTARGETS-
dc.subject.keywordPlusMODELS-
Appears in Collections:
KIST Article > 2014
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE